Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 15: 730-736, 1969;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moore, J. J.
Right arrow Articles by Sax, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moore, J. J.
Right arrow Articles by Sax, S. M.

Clinical Chemistry, Vol 15, 730-736, Copyright © 1969 by the American Association for Clinical Chemistry

Serum Glutamic Oxalacetic Transaminase Assay Using the Sequential Multiple Analyzer (SMA 12/30)

John J. Moore 1 and Sylvan M. Sax 1

1 Pathology Department, The Western Pennsylvania Hospital, Pittsburgh, Pa 15224.

The SMA-12/30 method for serum glutamic oxalacetic transaminase assay gives higher values than are obtained with a reference spectrophotometric method for some serums. A modification of the manifold is made to permit the running of serum blanks. Blank corrections on 466 serum samples indicate that dialysis does not eliminate the need for the blank determination. Acetoacetate interferes in the SMA-12/30 method. The possibility of other interfering substances has not been ruled out.

Submitted on August 27, 1968
Accepted on November 18, 1968






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1969 by the American Association for Clinical Chemistry.